Neuroprotective Tri- and Tetracyclic BChE Inhibitors Releasing Reversible Inhibitors upon Carbamate Transfer
Authors:
- 22 August 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 3 (11) , 914-919
Abstract
Tri- and tetracyclic nitrogen-bridgehead compounds were designed and synthesized to yield micromolar cholinesterase (ChE) inhibitors. Structure–activity relationships identified potent compounds with butyrylcholinesterase selectivity. These compounds were selected as starting points for the design and synthesis of carbamate-based (pseudo)irreversible inhibitors. Compounds with superior inhibitory activity and selectivity were obtained and kinetically characterized also with regard to the velocity of enzyme carbamoylation. Structural elements were identified and introduced that additionally showed neuroprotective properties on a hippocampal neuronal cell line (HT-22) after glutamate-induced intracellular reactive oxygen species generation. We have identified potent and selective pseudoirreversible butyrylcholinesterase inhibitors that release reversible inhibitors with neuroprotective properties after carbamate transfer to the active site of cholinesterases.Keywords
This publication has 28 references indexed in Scilit:
- Mycobacterium tuberculosis and cholinesterase inhibitors from Voacanga globosaEuropean Journal of Medicinal Chemistry, 2011
- Natural products as a source of Alzheimer's drug leadsNatural Product Reports, 2010
- Isosorbide-2-benzyl Carbamate-5-salicylate, A Peripheral Anionic Site Binding Subnanomolar Selective Butyrylcholinesterase InhibitorJournal of Medicinal Chemistry, 2010
- Rational design of a drug for Alzheimer's disease with cholinesterase inhibitory and neuroprotective activityChemico-Biological Interactions, 2008
- Design and synthesis of tacrine–ferulic acid hybrids as multi-potent anti-Alzheimer drug candidatesBioorganic & Medicinal Chemistry Letters, 2008
- Role of oxidative stress on β-amyloid neurotoxicity elicited during impairment of energy metabolism in the hippocampus: Protection by antioxidantsExperimental Neurology, 2006
- A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 2005
- Design, Synthesis, and Biological Evaluation of Conformationally Restricted Rivastigmine AnaloguesJournal of Medicinal Chemistry, 2004
- Cholinergic function and Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 2003
- Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stressNeuron, 1989